Advisor Group Holdings, Inc. Replimune Group, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Replimune Group, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 26,106 shares of REPL stock, worth $267,586. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,106
Previous 106
24528.3%
Holding current value
$267,586
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding REPL
# of Institutions
196Shares Held
77.6MCall Options Held
2.06MPut Options Held
2.86M-
Baker Bros. Advisors LP New York, NY11MShares$113 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$111 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$48.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$47.8 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$40.1 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $505M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...